Cargando…
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
Osteoprotegerin (OPG) is a glycoprotein involved in bone metabolisms and with a regulatory role in immune, skeletal and vascular systems. Recently, circulating OPG levels have emerged as independent biomarkers of cardiovascular disease (CVD) in patients with acute or chronic heart disease, as well a...
Autor principal: | Bjerre, Mette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863400/ https://www.ncbi.nlm.nih.gov/pubmed/24349960 http://dx.doi.org/10.1186/2193-1801-2-658 |
Ejemplares similares
-
Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
por: Wasilewska, Anna, et al.
Publicado: (2010) -
Osteoprotegerin (OPG) gene therapy in animal models of osteoarticular disease
por: Bolon, B, et al.
Publicado: (2001) -
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
por: Dutka, Mieczysław, et al.
Publicado: (2021) -
Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease
por: Bernardi, Stella, et al.
Publicado: (2016) -
Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats
por: Wang, Yan, et al.
Publicado: (2011)